Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems

Schistosomiasis is one of the 17 neglected tropical diseases prioritized by the World Health Organization. It affects hundreds of millions of people in developing countries in the poorest tropical and subtropical regions of the world. Today, essentially a single drug, praziquantel (PZQ), is availabl...

Full description

Bibliographic Details
Main Authors: Guidi, Alessandra, Lalli, Cristiana, Perlas, Emerald, Bolasco, Giulia, Nibbio, Martina, Monteagudo, Edith, Bresciani, Alberto, Ruberti, Giovina
Format: Online
Language:English
Published: Public Library of Science 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982595/
id pubmed-4982595
recordtype oai_dc
spelling pubmed-49825952016-08-29 Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems Guidi, Alessandra Lalli, Cristiana Perlas, Emerald Bolasco, Giulia Nibbio, Martina Monteagudo, Edith Bresciani, Alberto Ruberti, Giovina Research Article Schistosomiasis is one of the 17 neglected tropical diseases prioritized by the World Health Organization. It affects hundreds of millions of people in developing countries in the poorest tropical and subtropical regions of the world. Today, essentially a single drug, praziquantel (PZQ), is available to treat this parasitic disease. PZQ incomplete efficacy across all stages of the Schistosoma mansoni life cycle in the definitive host and the potential risk of drug resistance prompted us to search for novel schistosomicidal molecules. We screened a compound collection library using the larval stage of the parasite and discovered novel anti-schistosomal properties of perhexiline maleate (PHX). Overall, our study demonstrated that the anti-anginal drug PHX, still used in some countries, is active in vitro against parasite life stages poorly sensitive to PZQ. In addition, we showed that PHX impairs egg production in mature worm couples in vitro and damages the female and male reproductive systems and the male worm tegument. PHX could therefore represent a promising starting point for novel schistosomicidal drug discovery programmes. Public Library of Science 2016-08-12 /pmc/articles/PMC4982595/ /pubmed/27518281 http://dx.doi.org/10.1371/journal.pntd.0004928 Text en © 2016 Guidi et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Guidi, Alessandra
Lalli, Cristiana
Perlas, Emerald
Bolasco, Giulia
Nibbio, Martina
Monteagudo, Edith
Bresciani, Alberto
Ruberti, Giovina
spellingShingle Guidi, Alessandra
Lalli, Cristiana
Perlas, Emerald
Bolasco, Giulia
Nibbio, Martina
Monteagudo, Edith
Bresciani, Alberto
Ruberti, Giovina
Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems
author_facet Guidi, Alessandra
Lalli, Cristiana
Perlas, Emerald
Bolasco, Giulia
Nibbio, Martina
Monteagudo, Edith
Bresciani, Alberto
Ruberti, Giovina
author_sort Guidi, Alessandra
title Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems
title_short Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems
title_full Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems
title_fullStr Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems
title_full_unstemmed Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems
title_sort discovery and characterization of novel anti-schistosomal properties of the anti-anginal drug, perhexiline and its impact on schistosoma mansoni male and female reproductive systems
description Schistosomiasis is one of the 17 neglected tropical diseases prioritized by the World Health Organization. It affects hundreds of millions of people in developing countries in the poorest tropical and subtropical regions of the world. Today, essentially a single drug, praziquantel (PZQ), is available to treat this parasitic disease. PZQ incomplete efficacy across all stages of the Schistosoma mansoni life cycle in the definitive host and the potential risk of drug resistance prompted us to search for novel schistosomicidal molecules. We screened a compound collection library using the larval stage of the parasite and discovered novel anti-schistosomal properties of perhexiline maleate (PHX). Overall, our study demonstrated that the anti-anginal drug PHX, still used in some countries, is active in vitro against parasite life stages poorly sensitive to PZQ. In addition, we showed that PHX impairs egg production in mature worm couples in vitro and damages the female and male reproductive systems and the male worm tegument. PHX could therefore represent a promising starting point for novel schistosomicidal drug discovery programmes.
publisher Public Library of Science
publishDate 2016
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982595/
_version_ 1613626672413671424